FDA Uloric Warning Renews Concerns over Older Gout Drug Allopurinol

Posted on Posted in Zyloprim and Allopurinol

Terry Turner, Drugwatch The number of people taking the gout medication allopurinol has been rising as gout becomes more prevalent. Prescriptions also got a boost after the U.S. Food and Drug Administration limited the use of Uloric (febuxostat) in 2019, effectively leaving allopurinol as the primary first-line medication option for gout patients. But at the […]

Gout Flare Common Following Allopurinol Discontinuation

Posted on Posted in Zyloprim and Allopurinol

It is necessary to continue urate-lowering therapy in the inpatient setting to decrease the risk of gout flare in hospitalized patients.   GoutĀ flare is almost 14-times more likely to develop in hospitalized patients who have allopurinol discontinued upon admission compared to those who have the treatment continued, according to new study findings. The findings, presented […]